Not checked for notices yet.
Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy
Abdul Rashid Issahaku, Namutula Mukelabai, Clement Agoni and 4 more (opens in a new tab)
Scientific Reports · 2022
doi:10.1038/s41598-022-22668-1 (opens in a new tab)
Cited by papers we hold 1
Questions about this paper
We email you if it is retracted, withdrawn, corrected or flagged.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.